BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 7939523)

  • 1. [Atrial fibrillation: anticoagulants or not?].
    Zimmermann M
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1560-5. PubMed ID: 7939523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of embolisms in atrial fibrillation: anticoagulation and antiplatelet therapy].
    Kienast J
    Z Kardiol; 1994; 83 Suppl 5():49-58. PubMed ID: 7846945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation and atrial fibrillation.
    Atwood JE; Albers GW
    Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials.
    Albers GW; Sherman DG; Gress DR; Paulseth JE; Petersen P
    Ann Neurol; 1991 Oct; 30(4):511-8. PubMed ID: 1789680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation in patients with atrial fibrillation].
    Mügge A
    Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anticoagulant therapy in atrial fibrillation.
    Kottkamp H; Hindricks G; Breithardt G
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S86-96. PubMed ID: 9727682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.
    Singer DE
    Proc Assoc Am Physicians; 1996 Jan; 108(1):29-36. PubMed ID: 8834062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in nonvalvular atrial fibrillation.
    Borresen T
    J La State Med Soc; 1996 Nov; 148(11):479-84. PubMed ID: 8990787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.
    Odén A; Fahlén M; Hart RG
    Thromb Res; 2006; 117(5):493-9. PubMed ID: 16517250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
    N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.